デュポンの分析: ROE、ROA、純利益率の内訳
四半期データ
ROEを2つのコンポーネントに分解
Amgen Inc.、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
ROE |
= |
ROA |
× |
財務レバレッジ比率 |
2024/12/31 |
69.59% |
= |
4.45% |
× |
15.63 |
2024/09/30 |
56.20% |
= |
4.65% |
× |
12.07 |
2024/06/30 |
52.83% |
= |
3.44% |
× |
15.34 |
2024/03/31 |
74.93% |
= |
4.05% |
× |
18.51 |
2023/12/31 |
107.78% |
= |
6.91% |
× |
15.59 |
2023/09/30 |
98.82% |
= |
8.36% |
× |
11.83 |
2023/06/30 |
117.67% |
= |
8.84% |
× |
13.31 |
2023/03/31 |
148.04% |
= |
8.92% |
× |
16.59 |
2022/12/31 |
178.97% |
= |
10.06% |
× |
17.79 |
2022/09/30 |
187.11% |
= |
10.73% |
× |
17.44 |
2022/06/30 |
271.85% |
= |
11.09% |
× |
24.51 |
2022/03/31 |
624.78% |
= |
9.67% |
× |
64.62 |
2021/12/31 |
87.96% |
= |
9.63% |
× |
9.13 |
2021/09/30 |
68.26% |
= |
8.63% |
× |
7.91 |
2021/06/30 |
69.67% |
= |
9.61% |
× |
7.25 |
2021/03/31 |
75.91% |
= |
11.33% |
× |
6.70 |
2020/12/31 |
77.20% |
= |
11.54% |
× |
6.69 |
2020/09/30 |
— |
= |
— |
× |
5.90 |
2020/06/30 |
— |
= |
— |
× |
6.10 |
2020/03/31 |
— |
= |
— |
× |
6.50 |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の株主資本利益率(ROE)が上昇した主な理由は、財務レバレッジ比率の上昇です。
ROEを3つの要素に分解
Amgen Inc.、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
|
|
ROE |
= |
純利益率 |
× |
資産回転率 |
× |
財務レバレッジ比率 |
2024/12/31 |
69.59% |
= |
12.77% |
× |
0.35 |
× |
15.63 |
2024/09/30 |
56.20% |
= |
13.58% |
× |
0.34 |
× |
12.07 |
2024/06/30 |
52.83% |
= |
10.60% |
× |
0.32 |
× |
15.34 |
2024/03/31 |
74.93% |
= |
13.35% |
× |
0.30 |
× |
18.51 |
2023/12/31 |
107.78% |
= |
24.96% |
× |
0.28 |
× |
15.59 |
2023/09/30 |
98.82% |
= |
29.52% |
× |
0.28 |
× |
11.83 |
2023/06/30 |
117.67% |
= |
31.52% |
× |
0.28 |
× |
13.31 |
2023/03/31 |
148.04% |
= |
31.77% |
× |
0.28 |
× |
16.59 |
2022/12/31 |
178.97% |
= |
26.42% |
× |
0.38 |
× |
17.79 |
2022/09/30 |
187.11% |
= |
27.88% |
× |
0.38 |
× |
17.44 |
2022/06/30 |
271.85% |
= |
26.73% |
× |
0.41 |
× |
24.51 |
2022/03/31 |
624.78% |
= |
23.42% |
× |
0.41 |
× |
64.62 |
2021/12/31 |
87.96% |
= |
24.25% |
× |
0.40 |
× |
9.13 |
2021/09/30 |
68.26% |
= |
23.03% |
× |
0.37 |
× |
7.91 |
2021/06/30 |
69.67% |
= |
23.80% |
× |
0.40 |
× |
7.25 |
2021/03/31 |
75.91% |
= |
29.60% |
× |
0.38 |
× |
6.70 |
2020/12/31 |
77.20% |
= |
29.97% |
× |
0.39 |
× |
6.69 |
2020/09/30 |
— |
= |
— |
× |
— |
× |
5.90 |
2020/06/30 |
— |
= |
— |
× |
— |
× |
6.10 |
2020/03/31 |
— |
= |
— |
× |
— |
× |
6.50 |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の株主資本利益率(ROE)が上昇した主な理由は、財務レバレッジ比率の上昇です。
ROEを5つの要素に分解
Amgen Inc.、 ROE の分解(四半期データ)
|
|
|
|
|
|
|
|
|
|
|
|
|
ROE |
= |
税負担 |
× |
利息負担 |
× |
EBITマージン |
× |
資産回転率 |
× |
財務レバレッジ比率 |
2024/12/31 |
69.59% |
= |
0.89 |
× |
0.59 |
× |
24.24% |
× |
0.35 |
× |
15.63 |
2024/09/30 |
56.20% |
= |
0.90 |
× |
0.59 |
× |
25.39% |
× |
0.34 |
× |
12.07 |
2024/06/30 |
52.83% |
= |
0.89 |
× |
0.52 |
× |
22.81% |
× |
0.32 |
× |
15.34 |
2024/03/31 |
74.93% |
= |
0.87 |
× |
0.58 |
× |
26.62% |
× |
0.30 |
× |
18.51 |
2023/12/31 |
107.78% |
= |
0.86 |
× |
0.73 |
× |
39.87% |
× |
0.28 |
× |
15.59 |
2023/09/30 |
98.82% |
= |
0.86 |
× |
0.78 |
× |
43.78% |
× |
0.28 |
× |
11.83 |
2023/06/30 |
117.67% |
= |
0.87 |
× |
0.82 |
× |
44.53% |
× |
0.28 |
× |
13.31 |
2023/03/31 |
148.04% |
= |
0.87 |
× |
0.85 |
× |
43.21% |
× |
0.28 |
× |
16.59 |
2022/12/31 |
178.97% |
= |
0.89 |
× |
0.84 |
× |
35.29% |
× |
0.38 |
× |
17.79 |
2022/09/30 |
187.11% |
= |
0.88 |
× |
0.85 |
× |
36.93% |
× |
0.38 |
× |
17.44 |
2022/06/30 |
271.85% |
= |
0.88 |
× |
0.86 |
× |
35.55% |
× |
0.41 |
× |
24.51 |
2022/03/31 |
624.78% |
= |
0.88 |
× |
0.84 |
× |
31.62% |
× |
0.41 |
× |
64.62 |
2021/12/31 |
87.96% |
= |
0.88 |
× |
0.85 |
× |
32.51% |
× |
0.40 |
× |
9.13 |
2021/09/30 |
68.26% |
= |
0.87 |
× |
0.85 |
× |
31.31% |
× |
0.37 |
× |
7.91 |
2021/06/30 |
69.67% |
= |
0.88 |
× |
0.85 |
× |
31.83% |
× |
0.40 |
× |
7.25 |
2021/03/31 |
75.91% |
= |
0.89 |
× |
0.87 |
× |
38.31% |
× |
0.38 |
× |
6.70 |
2020/12/31 |
77.20% |
= |
0.89 |
× |
0.87 |
× |
38.76% |
× |
0.39 |
× |
6.69 |
2020/09/30 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
5.90 |
2020/06/30 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
6.10 |
2020/03/31 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
× |
6.50 |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の株主資本利益率(ROE)が上昇した主な理由は、財務レバレッジ比率の上昇です。
ROAを2つのコンポーネントに分解
Amgen Inc.、 ROA の分解(四半期データ)
|
|
|
|
|
|
|
ROA |
= |
純利益率 |
× |
資産回転率 |
2024/12/31 |
4.45% |
= |
12.77% |
× |
0.35 |
2024/09/30 |
4.65% |
= |
13.58% |
× |
0.34 |
2024/06/30 |
3.44% |
= |
10.60% |
× |
0.32 |
2024/03/31 |
4.05% |
= |
13.35% |
× |
0.30 |
2023/12/31 |
6.91% |
= |
24.96% |
× |
0.28 |
2023/09/30 |
8.36% |
= |
29.52% |
× |
0.28 |
2023/06/30 |
8.84% |
= |
31.52% |
× |
0.28 |
2023/03/31 |
8.92% |
= |
31.77% |
× |
0.28 |
2022/12/31 |
10.06% |
= |
26.42% |
× |
0.38 |
2022/09/30 |
10.73% |
= |
27.88% |
× |
0.38 |
2022/06/30 |
11.09% |
= |
26.73% |
× |
0.41 |
2022/03/31 |
9.67% |
= |
23.42% |
× |
0.41 |
2021/12/31 |
9.63% |
= |
24.25% |
× |
0.40 |
2021/09/30 |
8.63% |
= |
23.03% |
× |
0.37 |
2021/06/30 |
9.61% |
= |
23.80% |
× |
0.40 |
2021/03/31 |
11.33% |
= |
29.60% |
× |
0.38 |
2020/12/31 |
11.54% |
= |
29.97% |
× |
0.39 |
2020/09/30 |
— |
= |
— |
× |
— |
2020/06/30 |
— |
= |
— |
× |
— |
2020/03/31 |
— |
= |
— |
× |
— |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の総資産利益率(ROA)の低下の主な理由は、純利益率で測定した収益性の低下です。
ROAを4つの要素に分解
Amgen Inc.、 ROA の分解(四半期データ)
|
|
|
|
|
|
|
|
|
|
|
ROA |
= |
税負担 |
× |
利息負担 |
× |
EBITマージン |
× |
資産回転率 |
2024/12/31 |
4.45% |
= |
0.89 |
× |
0.59 |
× |
24.24% |
× |
0.35 |
2024/09/30 |
4.65% |
= |
0.90 |
× |
0.59 |
× |
25.39% |
× |
0.34 |
2024/06/30 |
3.44% |
= |
0.89 |
× |
0.52 |
× |
22.81% |
× |
0.32 |
2024/03/31 |
4.05% |
= |
0.87 |
× |
0.58 |
× |
26.62% |
× |
0.30 |
2023/12/31 |
6.91% |
= |
0.86 |
× |
0.73 |
× |
39.87% |
× |
0.28 |
2023/09/30 |
8.36% |
= |
0.86 |
× |
0.78 |
× |
43.78% |
× |
0.28 |
2023/06/30 |
8.84% |
= |
0.87 |
× |
0.82 |
× |
44.53% |
× |
0.28 |
2023/03/31 |
8.92% |
= |
0.87 |
× |
0.85 |
× |
43.21% |
× |
0.28 |
2022/12/31 |
10.06% |
= |
0.89 |
× |
0.84 |
× |
35.29% |
× |
0.38 |
2022/09/30 |
10.73% |
= |
0.88 |
× |
0.85 |
× |
36.93% |
× |
0.38 |
2022/06/30 |
11.09% |
= |
0.88 |
× |
0.86 |
× |
35.55% |
× |
0.41 |
2022/03/31 |
9.67% |
= |
0.88 |
× |
0.84 |
× |
31.62% |
× |
0.41 |
2021/12/31 |
9.63% |
= |
0.88 |
× |
0.85 |
× |
32.51% |
× |
0.40 |
2021/09/30 |
8.63% |
= |
0.87 |
× |
0.85 |
× |
31.31% |
× |
0.37 |
2021/06/30 |
9.61% |
= |
0.88 |
× |
0.85 |
× |
31.83% |
× |
0.40 |
2021/03/31 |
11.33% |
= |
0.89 |
× |
0.87 |
× |
38.31% |
× |
0.38 |
2020/12/31 |
11.54% |
= |
0.89 |
× |
0.87 |
× |
38.76% |
× |
0.39 |
2020/09/30 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
2020/06/30 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
2020/03/31 |
— |
= |
— |
× |
— |
× |
— |
× |
— |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の総資産利益率(ROA)が低下した主な理由は、EBITマージン率で測定した営業利益率の低下です。
当期純利益率の分解
Amgen Inc.、純利益率の分解(四半期データ)
|
|
|
|
|
|
|
|
|
純利益率 |
= |
税負担 |
× |
利息負担 |
× |
EBITマージン |
2024/12/31 |
12.77% |
= |
0.89 |
× |
0.59 |
× |
24.24% |
2024/09/30 |
13.58% |
= |
0.90 |
× |
0.59 |
× |
25.39% |
2024/06/30 |
10.60% |
= |
0.89 |
× |
0.52 |
× |
22.81% |
2024/03/31 |
13.35% |
= |
0.87 |
× |
0.58 |
× |
26.62% |
2023/12/31 |
24.96% |
= |
0.86 |
× |
0.73 |
× |
39.87% |
2023/09/30 |
29.52% |
= |
0.86 |
× |
0.78 |
× |
43.78% |
2023/06/30 |
31.52% |
= |
0.87 |
× |
0.82 |
× |
44.53% |
2023/03/31 |
31.77% |
= |
0.87 |
× |
0.85 |
× |
43.21% |
2022/12/31 |
26.42% |
= |
0.89 |
× |
0.84 |
× |
35.29% |
2022/09/30 |
27.88% |
= |
0.88 |
× |
0.85 |
× |
36.93% |
2022/06/30 |
26.73% |
= |
0.88 |
× |
0.86 |
× |
35.55% |
2022/03/31 |
23.42% |
= |
0.88 |
× |
0.84 |
× |
31.62% |
2021/12/31 |
24.25% |
= |
0.88 |
× |
0.85 |
× |
32.51% |
2021/09/30 |
23.03% |
= |
0.87 |
× |
0.85 |
× |
31.31% |
2021/06/30 |
23.80% |
= |
0.88 |
× |
0.85 |
× |
31.83% |
2021/03/31 |
29.60% |
= |
0.89 |
× |
0.87 |
× |
38.31% |
2020/12/31 |
29.97% |
= |
0.89 |
× |
0.87 |
× |
38.76% |
2020/09/30 |
— |
= |
— |
× |
— |
× |
— |
2020/06/30 |
— |
= |
— |
× |
— |
× |
— |
2020/03/31 |
— |
= |
— |
× |
— |
× |
— |
レポートに基づく:
10-K (報告日: 2024-12-31), 10-Q (報告日: 2024-09-30), 10-Q (報告日: 2024-06-30), 10-Q (報告日: 2024-03-31), 10-K (報告日: 2023-12-31), 10-Q (報告日: 2023-09-30), 10-Q (報告日: 2023-06-30), 10-Q (報告日: 2023-03-31), 10-K (報告日: 2022-12-31), 10-Q (報告日: 2022-09-30), 10-Q (報告日: 2022-06-30), 10-Q (報告日: 2022-03-31), 10-K (報告日: 2021-12-31), 10-Q (報告日: 2021-09-30), 10-Q (報告日: 2021-06-30), 10-Q (報告日: 2021-03-31), 10-K (報告日: 2020-12-31), 10-Q (報告日: 2020-09-30), 10-Q (報告日: 2020-06-30), 10-Q (報告日: 2020-03-31).
2024年第4 四半期の純利益率の低下の主な理由は、EBITマージン率で測定した営業利益率の低下です。